IOSPINNOSPEC INC.
Chemicals & Allied Products
- Revenue
- $1.8B
- 3.7% YoY
- Operating margin
- 7.3%
- 24% YoY
- EBITDA
- $173M
- 22% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -1.4×
- −$250M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear116% of net incomeCash flow under 80% of net income
- Dilutive SBCClear0% of revenueOver 10% of revenue
- Payouts exceed cash flowClear48% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear22% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $2.0B | $1.9B | $1.8B | $1.8B | 3.7% |
| Operating income | $132M | $187M | $162M | $178M | $130M | 27% |
| Operating cash flow | $93M | $82M | $207M | $185M | $138M | 25% |
| Stock-based comp | $4M | $7M | $8M | $9M | $8M | 4.7% |
| Buybacks | $800K | $6M | $1M | $700K | $24M | 3314% |
| Dividends | $29M | $32M | $35M | $39M | $42M | 9.3% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.